Outcomes of allogeneic haematopoietic stem cell transplantation from HLA-matched and alternative donors: a European Society for Blood and Marrow Transplantation registry retrospective analysis
Top Cited Papers
- 1 November 2019
- journal article
- research article
- Published by Elsevier in The Lancet Haematology
- Vol. 6 (11) , e573-e584
Abstract
No abstract availableKeywords
Funding Information
- Tel Aviv University
This publication has 31 references indexed in Scilit:
- Biology-Driven Approaches to Prevent and Treat Relapse of Myeloid Neoplasia after Allogeneic Hematopoietic Stem Cell TransplantationTransplantation and Cellular Therapy, 2019
- Recipients Receiving Better HLA-Matched Hematopoietic Cell Transplantation Grafts, Uncovered by a Novel HLA Typing Method, Have Superior Survival: A Retrospective StudyTransplantation and Cellular Therapy, 2019
- Multiple imputation using chained equations: Issues and guidance for practiceStatistics in Medicine, 2010
- Reduced Mortality after Allogeneic Hematopoietic-Cell TransplantationNew England Journal of Medicine, 2010
- Defining the Intensity of Conditioning Regimens: Working DefinitionsTransplantation and Cellular Therapy, 2009
- Standard graft-versus-host disease prophylaxis with or without anti-T-cell globulin in haematopoietic cell transplantation from matched unrelated donors: a randomised, open-label, multicentre phase 3 trialThe Lancet Oncology, 2009
- Quantification of the completeness of follow-upThe Lancet, 2002
- Allogeneic bone marrow transplantation for chronic myelogenous leukemia: comparative analysis of unrelated versus matched sibling donor transplantationBlood, 2002
- Effectiveness of Donor Natural Killer Cell Alloreactivity in Mismatched Hematopoietic TransplantsScience, 2002
- Graft-versus-leukemia reactions after bone marrow transplantationBlood, 1990